SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Turnover for the quarter ended September 2022 of Rs. 209.43 millions increase by 74.82% from Rs. 119.80 millions.The Net Loss for the quarter ended September 2022 is Rs. -40.62 millions as compared to Net Loss of Rs. -108.49 millions of corresponding quarter ended September 2021 Operating profit Margin for the quarter ended September 2022 improved to -16.27% as compared to -76.57% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 209.43 119.80 74.82 315.84 187.35 68.58 597.03 537.00 11.18
Other Income 2.75 1.32 108.33 4.04 1.62 149.38 11.56 6.21 86.15
PBIDT -16.27 -76.57 -78.75 -77.66 -141.53 -45.13 -328.39 -169.56 93.67
Interest 7.42 17.76 -58.22 10.46 32.88 -68.19 53.91 62.79 -14.14
PBDT -23.69 -94.33 -74.89 -88.12 -174.41 -49.48 -382.30 -232.35 64.54
Depreciation 16.93 14.16 19.56 33.86 28.32 19.56 62.97 51.24 22.89
PBT -40.62 -108.49 -62.56 -121.98 -202.73 -39.83 -445.27 -283.59 57.01
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -40.62 -108.49 -62.56 -121.98 -202.73 -39.83 -445.27 -283.59 57.01
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 196.21 9.89
PBIDTM(%) -7.77 -63.91 -87.85 -24.59 -75.54 -67.45 -55.00 -31.58 74.20

Krebs Biochem.&Inds Share Price

60.90 -0.12 (-0.20%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×